UniProt | Protein Name |
---|---|
P04180 |
|
A0A140VK24 |
|
GO Term | Evidence Code | PMID |
---|---|---|
lipoprotein biosynthetic process | ||
high-density lipoprotein particle remodeling | ||
lipid metabolic process | ||
regulation of high-density lipoprotein particle assembly | ||
reverse cholesterol transport |
GO Term | Evidence Code | PMID |
---|---|---|
high-density lipoprotein particle | ||
extracellular region |
|
|
extracellular space | ||
extracellular exosome |
GO Term | Evidence Code | PMID |
---|---|---|
1-alkyl-2-acetylglycerophosphocholine esterase activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:0111369 | hyperalphalipoproteinemia 1 | |
DOID:10127 | cerebral artery occlusion | |
DOID:10138 | xerophthalmia | |
DOID:10140 | dry eye syndrome | |
DOID:10230 | aortic atherosclerosis | |
DOID:10595 | Charcot-Marie-Tooth disease | |
DOID:10652 | Alzheimer's disease | |
DOID:1074 | kidney failure | |
DOID:10923 | sickle cell anemia | |
DOID:10952 | nephritis |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000083 | Renal insufficiency |
HP:0000093 | Proteinuria |
HP:0000505 | Visual impairment |
HP:0001084 | Corneal arcus |
HP:0001681 | Angina pectoris |
HP:0001744 | Splenomegaly |
HP:0001878 | Hemolytic anemia |
HP:0001895 | Normochromic anemia |
HP:0002155 | Hypertriglyceridemia |
Disease ID | Disease Name |
---|---|
ORPHA:79292 |
|
OMIM:245900 |
|
OMIM:136120 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
113445308 | PSETE18151 | ||
100073500 | ORNAN27636 | ||
100916426 | SARHA03186 | ||
108587667 | CALJA21642 | ||
102126888 | MACFA25176 | ||
701872 | MACMU25819 | ||
105491393 | MACNE07777 | ||
100126664 | PAPAN15586 | ||
105551486 | MANLE34900 | ||
109023671 | GORGO12122 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024